| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 52 Number 1
Volume 51 Number 6
Volume 51S Number 2
Volume 51 Number 5
Volume 51 Number 4
Volume 51 Number 3
Earlier issues
Volume 49 Number 3


Research articles

ScienceAsia 52 (2026): 1-9 |doi: 10.2306/scienceasia1513-1874.2026.030


The anti-hepatitis B virus efficacy of Gymnema sylvestre and Hemidesmus indicus: Cell culture and HPLC validations


Sakina Niyazia, Mohammad K. Parvezb,*, Tanzeel Ahmeda,*, Shama Parveenc, Mohammed S. Al-Dosarib, Rashed N. Herqashb, Abdullah R. Alanzib, Ghanshyam P. Sinhad

 
ABSTRACT:     Despite the availability of effective antiviral therapeutics, drug resistance in HBV still remains a clinical challenge. Nonetheless, a wide range of anti-HBV natural products comprising plant preparations or isolated compounds have been identified. Of these, some of the globally used herbal products have been reported to cause serious adverse effects, or hepatotoxicity. Here, we pre-tested the non-hepatotoxicity (dimethylthiazolyl diphenyltetrazolium bromide; MTTassay)ofGymnemasylvestre(GM)andHemidesmusindicus(HI)totalethanolextract (Ext) and fractions (hexane: Hex, chloroform: Chl, ethyl acetate: EtAc, and ethanol: EtOH) in HepG2 cells before their anti-HBV assessment (HBV surface antigen/HBsAg and precore antigen/HBeAg ELISA) in HepG2.2.15 cells. Because all GM and HI preparations showed no sign of liver toxicity at the maximal dose (200 ?g/ml), the 50 ?g/ml dose was selected as the optimal inhibitory dose for testing time-course HBV activities. Of the tested preparations, GM-EtOH (HBsAg ?41.8%, HBeAg ?40%) and HI-EtOH (HBsAg ?39.6%, HBeAg ?38%) showed moderate activities, whereas GM-Hex(HBsAg?54.3%, HBeAg?52%),HI-Hex(HBsAg?50.2%, HBeAg?48.7%), GM-Chl(HBsAg?47.2%, HBeAg ?45.7%), and HI-Chl (HBsAg ?48.8%, HBeAg ?46.8%) exhibited high activities on day 5. Further quantitative RP HPLC analysis identified known anti-HBV flavanols and polyphenols in GM/HI extract (rutin: 48.28, 29.07; quercetin: 36.36, 16.35; kaempferol: 3.65, 6.50; caffeic acid: 56.59, 64.13; and chlorogenic acid: 8.36, 22.62 ?g/10 mg), attributed to their anti-HBV activities. Our data, therefore, convincingly and strongly warrant preclinical or clinical studies of the anti-HBV therapeutic potential of G. sylvestre and H. indicus.

Download PDF

Downloads Views


a School of Biotechnology, IFTM University, Moradabad 244102 India
b Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451 Saudi Arabia
c Center for Interdisciplinary Research in Basic Sciences, Jamila Millia Islamia Central University, New Delhi 110025 India
d Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213 USA

* Corresponding author, E-mail: mohkhalid@ksu.edu.sa, ahmed.tanzeel@gmail.com

Received 9 Sep 2025, Accepted 4 Mar 2026